Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
(18)Flurodeoxyglucose-PET Baseline Avidity Predicts for Inferior Outcomes in Patients With Locally-Advanced Pancreatic Cancer Treated With Gemcitabine and Stereotactic Body Radiation Therapy Dholakia, A. S., Chang, D. T., Goodman, K. A., Raman, S. P., Leal, J. P., Laheru, D. A., Wolfgang, C. L., Chaudhry, M., Koong, A. C., Herman, J. ELSEVIER SCIENCE INC. 2013: S308–S309
View details for DOI 10.1016/j.ijrobp.2013.06.810
View details for Web of Science ID 000324503601194